Imatinib
targeted anticancer therapy · kinase inhibitor
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Imatinib belongs to the 'targeted anticancer therapy (kinase inhibitor)' category. This targeted therapy attacks a specific mechanism of the tumour cells; it comes under a specialised hospital prescription.
For Imatinib, in practice: Treats a cancer by targeting tumour cells. Its prescription and administration fall within a specialised, often hospital, setting.
Under which brands it is found
Imatinib is found in around 12 presentations listed in France. It is available under various brand names and as generics.
- Imatinib Accord
- Imatinib Arrow Lab
- Imatinib Bgr
- Imatinib Cristers
- Imatinib Eg
- Imatinib Eg Labo
- Imatinib Hcs
- Imatinib Sandoz
- and other presentations
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
Nous n'avançons aucun complément pour Imatinib : ce serait forcer un besoin qui n'existe pas. La grande majorité des médicaments n'appellent aucune supplémentation particulière, et le reconnaître fait partie de notre manière de travailler. Nous ne concevons un complément que là où les données le soutiennent.
Related molecules
To explore in the « Other areas » family and its neighbours.